Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation.
Furukawa
Y
Y
Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario, Canada. Yoshiaki_Furukawa@camh.net
Guttman
M
M
Wong
H
H
Farrell
S A
SA
Furtado
S
S
Kish
S J
SJ
D019943:Amino Acid Substitution; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D005091:Exons / Q000235:genetics; D005260:Female; D006136:GTP Cyclohydrolase / Q000172:deficiency / Q000235:genetics*; D005799:Genes, Dominant; D006579:Heterozygote; D006801:Humans; D008297:Male; D020125:Mutation, Missense; D010375:Pedigree; D017354:Point Mutation; D011388:Prolactin / Q000097:blood*
D004295:Dihydroxyphenylalanine; D011388:Prolactin; D006136:GTP Cyclohydrolase